Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors
Clinical trial NCT01573780 · TERMINATED
Trial details
- NCT number
- NCT01573780
- Sponsor
- Roswell Park Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-09-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.